Shoulder Innovations Launches InSet™ I-135RFX Humeral Stem with Expanded FDA Clearance for All Shoulder Arthroplasty Procedures

summarizeSummary

Shoulder Innovations announced the full commercial launch of its InSet™ I-135RFX Humeral Stem, now cleared by the FDA for all primary, revision, and fracture total shoulder arthroplasty procedures, marking a significant expansion of its product line.

check_boxKey Events

• Full Commercial Launch of InSet™ I-135RFX Humeral Stem

  Shoulder Innovations, Inc. has initiated the full commercial launch of its InSet™ I-135RFX Humeral Stem, following a successful limited market release.

• Expanded FDA 510(k) Clearance

  The InSet™ I-135RFX Humeral Stem received additional FDA 510(k) clearance for an expanded set of fracture indications.

• Supports Full Spectrum of Shoulder Arthroplasty Procedures

  The expanded clearance enables the InSet™ I-135RFX to be utilized in all primary, revision, and fracture total shoulder arthroplasty procedures, broadening its market applicability.

• Third Addition to I-Series Product Line

  This product is the third addition to the InSet Humeral Stem System in as many years, highlighting the company's ongoing innovation in shoulder surgical care solutions.

auto_awesomeAnalysis

Shoulder Innovations, Inc. announced the full commercial launch of its InSet™ I-135RFX Humeral Stem, a significant product expansion following successful limited market release and expanded FDA 510(k) clearance. This new stem can now be used in all primary, revision, and fracture total shoulder arthroplasty procedures, broadening the company's addressable market and strengthening its product portfolio. As the third addition to the I-Series humeral stem product line in as many years, this launch demonstrates the company's consistent innovation and commitment to improving patient outcomes across the full spectrum of shoulder surgical care. This development is positive for future revenue growth, building on the 49.6% net revenue increase reported in the last fiscal year.